Cybin
Price & Volume
Stats
See more52W Range | $3.76-$15.15 |
Market Cap | $774M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$4.15 |
News
See moreYahoo Finance • 2 months ago
FDA names acting heads of drug and vaccine units to permanent roles
Yahoo Finance • 3 months ago
Cybin reports Q1 results
Yahoo Finance • 3 months ago
Psychedelic Therapy Meets M&A: Fireside Chat with Jupiter Neurosciences CEO Christer Rosén & President Alison Silva
Yahoo Finance • 4 months ago
Helus Pharma™ Announces Closing of US$50 Million Underwritten Offering
About
CEO | Mr. Michael I. Halstead J.D. |
Address | 100 King Street West, Toronto, ON, Canada, M5X 1C9 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 100 |